1.McDonald, LC. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis 2006;42(suppl 2):S65–S71.
2.Crowe, M, Towner, K, Humphreys, H. Clinical and epidemiological features of outbreak of Acinetobacter infection in an intensive therapy unit. J Med Microbiol 1995;43:55–62.
3.Bergogne-Berezin, E, Towner, KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9:148–165.
4.Mah, MW, Memish, ZA, Cunningham, G, Bannatyne, RM. Outbreak of Acinetobacter baumannii in an intensive care unit associated with tracheostomy. Am J Infect Control 2001;29:284–288.
5.National Committee for Clinical and Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard. 6th ed. Wayne, PA: NCCLS; 2003: M7–A6.
6.Eltahawy, AT, Khalaf, RM. Antibiotic resistance among gram-negative non-fermentative bacteria at a teaching hospital in Saudi Arabia. J Chemother 2001;13:260–264.
7.Poirel, L, Menuteau, O, Agoli, N, Cattoen, C, Nordmann, P. Outbreak of extended-spectrum beta-lactamase VEB-l-producing isolates of Acinetobacter baumannii in a French Hospital. J Clin Microbiol 2003;41:3542–3547.
8.Wu, CJ, Lee, HC, Lee, NY, et al.Predominance of gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. J Microbiol Immunol Infect 2006;39:135–143.
9.Ishii, Y, Alba, J, Kimura, S, Yamaguchi, K. Evaluation of antimicrobial activity of beta-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004). Diagn Microbiol Infect Dis 2006;55:143–148.
10.Gales, AC, Jones, RN, Forward, KR, Linares, J, Sader, HS, Verhoef, J. Emerging importance of multi-drug resistant Acinetobacter species and Ste-notrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001;32(suppl 2):S104–S113.
11.Cisneros, JM, Rodriguez-Bano, J, Fernandez-Cuenca, F, et al.Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect 2005;11:874–879.
12.Thongpiyapoom, S, Narong, MN, Suwalak, N, et al.Device-associated infections and patterns of antimicrobial resistance in a medical-surgical intensive care unit in a university hospital in Thailand. J Med Assoc Thai 2004;87:819–824.
13.Pfaller, MA, Sader, HS, Fritsche, TR, Jones, RN. Antimicrobial activity of cefepime tested against ceftazidime-resistant gram-negative clinical strains from North American hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2006;56:63–68.
14.Mahmood, A, Karamat, KA, Butt, T. Neonatal sepsis: high antibiotic resistance of the bacterial pathogens in a neonatal intensive care unit in Karachi. J Pak Med Assoc 2002;52:348–350.
15.Hart, CA, Kariuki, S. Antimicrobial resistance in developing countries. BMJ 1998;317:647–650.